Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Exclusive: AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official
BRUSSELS (Reuters) - AstraZeneca Plc has told the European Union it expects to deliver less than half the COVID-19 vaccines it was contracted to supply in the second quarter, an EU official to...
Sanofi to provide manufacturing support to Johnson & Johnson for their COVID-19 vaccine to help address global supply demands
Sanofi has entered into an agreement with Janssen Pharmaceutical NV and Janssen Pharmaceuticals, Inc.
Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing
CHENGDU, CHINA, February 23, 2021—Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing transformative biologics as vaccines and therapeutics for the world’s most deb...
After Pfizer deal, Sanofi offers a hand to Johnson & Johnson for COVID-19 vaccine production
Sanofi hasn't abandoned its COVID-19 vaccine hopes despite a setback in the high-stakes race, but as it moves two different shots forward, it's also pitching in to make doses for its usual riv...
Doctors 'highly positive' on AbbVie's Rinvoq in IBD, but not so much on Bristol Myers' Zeposia: analyst
AbbVie’s Rinvoq just recently reported a pivotal trial win in ulcerative colitis, and one team of analysts is already drawing a rosy future for the next-gen immunology drug based on a physician surv...
BrainStorm Receives Feedback on Potential BLA Submission for ALS Therapy
The U.
AZ withdraws Imfinzi indication in the US for advanced bladder cancer
AstraZeneca (AZ) has announced the voluntary withdrawal of its immunotherapy Imfinzi in its advanced bladder cancer indication in the US.
An anti-aging medicine that removes senescent cells has been discovered
Japanese scientists have figured out how to stop aging and rejuvenate the body.
Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development
Charles River Laboratories International, Inc.
Scientists identify over 140,000 virus species in the human gut
Newswise — Viruses are the most numerous biological entities on the planet.
Entire Brazilian city will be vaccinated against COVID-19 in giant experiment
An entire Brazilian city will be vaccinated against COVID-19 in a giant experiment to test whether the vaccines reduce the spread of the virus.
Immunic, Inc. Announces Positive Top-Line Data From Investigator-Sponsored Phase 2 Proof-of-Concept Clinical Trial of IMU-838 in Primary Sclerosing Cholangitis
NEW YORK, NY, USA - February 18, 2021 - Immunic, Inc.
294
295
296
297
298
299
300
301
302
